Brandi Robinson | Senior Vice President, Corporate Affairs |
Gregory Divis | Chief Executive Officer |
Douglas Williamson | Chief Medical Officer |
Tom McHugh | Chief Financial Officer |
Richard Kim | Chief Commercial Officer |
Christopher Howerton | Jefferies |
David Amsellem | Piper Sandler & Co. |
Ami Fadia | Needham & Co. |
Paul Matteis | Stifel |
Oren Livnat | H.C. Wainwright & Co. LLC |
Matthew Kaplan | Ladenburg Thalmann & Co. Inc. |
Robin Garner | Craig Hallum |
Adam Evertts | LifeSci Capital, LLC |
Jason Gerberry | Bank of America Securities, Inc. |
Greetings, and welcome to the Avadel Pharmaceuticals Fourth Quarter and Full Year 2021 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal remarks.
As a reminder, this conference is being recorded. It is now my pleasure to introduce Brandi Robinson.